MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

OR-1896

CAS No. : 220246-81-1

MCE 国际站：OR-1896

产品活性：OR-1896 是 Levosimendan 的活性长寿代谢产物。OR-1896 是一种高选择性磷酸二酯酶 (PDE III) 抑制剂，是一种功能强大的血管扩张剂。OR-1896 可以打开 ATP 敏感的 K⁺ 通道，并具有 Ca²⁺ 致敏作用。OR-1896 可减轻心肌细胞的凋亡，心脏重塑和心肌炎症。

研究领域：Membrane Transporter/Ion Channel  |  Metabolic Enzyme/Protease  |  Apoptosis

作用靶点：Potassium Channel  |  Phosphodiesterase (PDE)  |  Drug Metabolite  |  Apoptosis

In Vitro: There are many evidences has accumulated and revealed a variety of beneficial pleiotropic effects OR-1896. OR-1896 evokes prominent vasodilatory responses, activation of ATP-sensitive sarcolemmal K⁺ channels of smooth muscle cells appears as a powerful vasodilator mechanism. Additionally, activation of ATP-sensitive K⁺ channels in the mitochondria potentially extends the range of cellular actions towards the modulation of mitochondrial ATP production and implicates a pharmacological mechanism for cardioprotection.

In Vivo: During the metabolism of Levosimendan approximately 5% of the drug is converted to the metabolite OR-1855 in the large intestine, and then acetylated in the liver to form the active metabolite OR-1896. Binding to plasma proteins is 98% for Levosimendan but only 40% for OR-1896. Unlike Levosimendan, which has an elimination half-life of 1-1.5 h, the half-life of OR-1896 is about 75 to 80 h allowing cardiovascular effects to persist up to 7 to 9 days after discontinuation of a 24-hour infusion of levosimendan. The pharmacokinetic of the parent drug is unaltered in subjects with severe renal impairment or with moderate hepatic impairment, whereas the elimination of its metabolites (OR-1896) can be prolonged.

相关产品：Bioactive Compound Library Plus  |  Apoptosis Compound Library  |  Membrane Transporter/Ion Channel Compound Library  |  Metabolism/Protease Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Anti-Alzheimer's Disease Compound Library  |  Neuroprotective Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Drug Metabolite Library  |  Anti-Colorectal Cancer Compound Library   |  Potassium Channel Compound Library  |  Human Metabolite Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Highly Selective Activators Library  |  SY-5609  |  BRD4 Inhibitor-18  |  Nicotinamide N-oxide  |  Mitiglinide-d₅ calcium  |  8α-Tigloyloxyhirsutinolide 13-O-acetate  |  Cirsiliol 4′-glucoside  |  Desglymidodrine  |  Cirsimarin  |  AAPK-25  |  Dutasteride-¹³C₆  |  Oleic acid-¹³C  |  PDE11-IN-1  |  Anticancer agent 120  |  Abacavir sulfate  |  Meloxicam-d₃-1  |  4-Methylamino antipyrine hydrochloride  |  Enpp-1-IN-2  |  Thailanstatin D  |  SB-218078  |  Tazarotenic acid-d₆  |  Toyocamycin  |  Sorafenib-d₄  |  Ropivacaine hydrochloride  |  Busulfan  |  PTC-028  |  Dinaciclib  |  CR-1-31-B  |  PAT-347  |  Vardenafil-d₅  |  142I5

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

货号: HY-135746

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。